中西医治疗肝性脑病的研究进展
Research Progress of Chinese and Western Medicine in the Treatment of Hepatic Encephalopathy
DOI: 10.12677/acm.2024.1451393, PDF,   
作者: 王 媛*:黑龙江中医药大学研究生院,黑龙江 哈尔滨;梁国英#:黑龙江中医药大学附属第一医院消化一科,黑龙江 哈尔滨
关键词: 肝性脑病肝硬化中西医治疗Hepatic Encephalopathy Liver Cirrhosis Chinese and Western Medicine Treatments
摘要: 肝性脑病是肝硬化常见的并发症之一,是一种严重危害人类健康的代谢性疾病。轻者注意力、执行功能均有所损害,定向力产生不同程度障碍,重者可发生无意识昏睡,甚至昏迷,种种表现给患者及家人带来了极大的痛苦和生活上沉重的负担。然而,目前针对肝性脑病的治疗尚未取得突破性进展,因此文章从中、西医两个方面对肝性脑病的治疗进行简要综述,旨在为临床治疗提供思路,实现创新性突破。
Abstract: Hepatic encephalopathy is one of the common complications of liver cirrhosis, which is a metabolic disease that seriously jeopardizes human health. In mild cases, attention and executive functions are impaired, and orientation is impaired to different degrees, while in severe cases, unconscious lethargy or even coma may occur, all of which bring great pain and heavy burden to patients and their families. However, the treatment of hepatic encephalopathy has not yet made any breakthrough progress. Therefore, this article reviews the treatment of hepatic encephalopathy from two aspects: Chinese and Western medicine, aiming to provide ideas for clinical treatment and realize innovative breakthroughs.
文章引用:王媛, 梁国英. 中西医治疗肝性脑病的研究进展[J]. 临床医学进展, 2024, 14(5): 41-46. https://doi.org/10.12677/acm.2024.1451393

参考文献

[1] 徐小元, 丁惠国, 李文刚, 等. 肝硬化肝性脑病诊疗指南[J]. 临床肝胆病杂志, 2018, 34(10): 2076-2089.
[2] Weissenborn, K. (2019) Hepatic Encephalopathy: Definition, Clinical Grading and Diagnostic Principles. Drugs, 79, 5-9. [Google Scholar] [CrossRef] [PubMed]
[3] Elsaid, M.I. and Rustgi, V.K. (2020) Epidemiology of Hepatic Encephalopathy. Clinics in Liver Disease, 24, 157-174. [Google Scholar] [CrossRef] [PubMed]
[4] Chen, Z.F., Ruan, J.S., Li, D.H., et al. (2021) The Role of Intestinal Bacteria and Gut-Brain Axis in Hepatic Encephalopathy. Frontiers in Cellular and Infection Microbiology, 10, 595759. [Google Scholar] [CrossRef] [PubMed]
[5] Hoilat, G.J., Ayas, M.F., Hoilat, J.N., et al. (2021) Polyethylene Glycol versus Lactulose in the Treatment of Hepatic Encephalopathy: A Systematic Review and Meta-Analysis. BMJ Open Gastroenterology, 8, e000648. [Google Scholar] [CrossRef] [PubMed]
[6] Wang, Z.D., Chu, P. and Wang, W.J. (2018) Combination of Rifaximin and Lactulose Improves Clinical Efficacy and Mortality in Patients with Hepatic Encephalopathy. Drug Design, Development and Therapy, 13, 1-11. [Google Scholar] [CrossRef
[7] Nardelli, S., Gioia, S., Faccioli, J., et al. (2023) Hepatic Encephalopathy—Recent Advances in Treatment and Diagnosis. Expert Review of Gastroenterology & Hepatology, 17, 225-235. [Google Scholar] [CrossRef] [PubMed]
[8] Jain, A., Sharma, B.C., Mahajan, B., et al. (2021) L-Ornithine L-Aspartate in Acute Treatment of Severe Hepatic Encephalopathy: A Double-Blind Randomized Controlled Trial. Hepatology, 75, 1194-1203. [Google Scholar] [CrossRef] [PubMed]
[9] 王军梅, 靳晓利. 微生态制剂辅助治疗肝硬化肝性脑病的疗效及对肠道菌群的影响[J]. 中国微生态学杂志, 2022, 34(1): 74-77, 90.
[10] Bajaj, J.S., Fagan, A., Gavis, E.A., et al. (2019) Long-Term Outcomes of Fecal Microbiota Transplantation in Patients with Cirrhosis. Gastroenterology, 156, 1921-1923.e3. [Google Scholar] [CrossRef] [PubMed]
[11] Bajaj, J.S., Salzman, N.H., Acharya, C., et al. (2019) Fecal Microbial Transplant Capsules Are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo-Controlled Trial. Hepatology, 70, 1690-1703. [Google Scholar] [CrossRef] [PubMed]
[12] 陈功海, 王广川, 张春清. 经颈静脉肝内门体分流术后肝性脑病的研究现状[J]. 临床肝胆病杂志, 2021, 37(5): 1201-1204.
[13] 李晶滢, 辛喜艳, 杨华升. 钱英辨治轻微型肝性脑病经验[J]. 中华中医药杂志, 2021, 36(7): 4022-4024.
[14] 钱斐, 薛博瑜, 王培, 等. 薛博瑜防治肝性脑病五法[J]. 中华中医药杂志, 2020, 35(4): 1817-1820.
[15] 蒋云霞, 罗伟生. 大黄及其提取物治疗肝脏疾病研究进展[J]. 山东中医杂志, 2020, 39(12): 1365-1368.
[16] 刘天华. 中西医结合治疗肝硬化轻微肝性脑病临床疗效观察[J]. 辽宁中医杂志, 2022, 49(1): 109-112.
[17] 范铭兴, 张曾娣, 缪红军. 安宫牛黄丸联合醒脑静注射液治疗肝性脑病临床观察[J]. 中华中医药学刊, 2020, 38(2): 237-240.
[18] 苗芙蕊, 麦威, 蒋筱. 隔姜灸期门、中脘穴对轻微型肝性脑病模型大鼠肝功能及脑内GSH-PX、CAT活力、LRP1表达的影响[J]. 时珍国医国药, 2021, 32(11): 2807-2810.
[19] 黄姬玲, 康英杰, 成建明, 等. 电针干预轻微型肝性脑病即刻脑效应的BOLD-fMRI研究[J]. 中国医学计算机成像杂志, 2022, 28(2): 119-126.